NCT07394946 2026-02-20
NELOPHER
Cancer Care Hospital & Research Centre Foundation, Lahore
Phase 2 Not yet recruiting
Clinical Trials
12 trialsNCT07305246 2025-12-26
Clinical Study of SHR-A1811 With or Without Letrozole in Neoadjuvant Therapy for Early-Stage HR-Positive, HER2-Low Breast Cancer
First Hospital of China Medical University
Phase 2 Not yet recruiting
NCT06223698 2025-04-20
SWE-Switch
Region Örebro County
Phase 3 Not yet recruiting
NCT06861803 2025-03-21
Laboratory and Ultrasound Findings and Response to Letrozole in PCOS Patients
Al-Azhar University
Not yet recruiting
NCT06810492 2025-03-17
The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment
Hubei Cancer Hospital
Phase NA Not yet recruiting
NCT06341283 2024-05-10
A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer
The Affiliated Hospital of Qingdao University
Not yet recruiting
NCT06405178 2024-05-08
Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian Syndrome
Beni-Suef University
Phase 3 Not yet recruiting
NCT06405243 2024-05-08
Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients
Beni-Suef University
Phase 3 Not yet recruiting
NCT06346457 2024-04-04
Breast Cancer & Antiestrogenic Therapy & Brain
International Research Training Group 2804
Not yet recruiting
NCT05979220 2023-08-07
Study of Dalpiciclib Combined With Letrozole in the Maintenance Treatment of HR Positive and HER2 Negative Metastatic Breast Cancer After First-line Chemotherapy
West China Hospital
Phase 2 Not yet recruiting
NCT05131893 2021-11-23
Neoadjuvant Treatment of Breast Cancer
National Institute of Oncology, Hungary
Not yet recruiting
NCT04137640 2021-07-20
Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy
Shengjing Hospital
Phase 4 Not yet recruiting